Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Net Shares Issued and Repurchased (2023 - 2025)

Nexalin Technology (NXL) posted Net Shares Issued and Repurchased of $1.1 million for Q4 2025, up 25.52% on a QoQ basis from $856870.0 in Q4 2024, and up 25.52% year-over-year from $856870.0 in Q4 2024.

Analysis

Nexalin Technology (NXL) Net Shares Issued and Repurchased (2023 - 2025) Analysis & Trends

Nexalin Technology has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $1.1 million in Q4 2025.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 25.52% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 25.52% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 25.52% from the prior year.
  • Net Shares Issued and Repurchased was $1.1 million for Q4 2025 at Nexalin Technology, up from $856870.0 in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $2.3 million in Q4 2023, with the low at $856870.0 in Q4 2024.
  • Average Net Shares Issued and Repurchased over 3 years is $1.6 million, with a median of $1.7 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased sank 62.45% in 2024, then advanced 25.52% in 2025.
  • Over 3 years, Net Shares Issued and Repurchased stood at $2.3 million in 2023, then tumbled by 62.45% to $856870.0 in 2024, then gained by 25.52% to $1.1 million in 2025.
  • The last three Net Shares Issued and Repurchased figures came in at $1.1 million (Q4 2025), $856870.0 (Q4 2024), and $2.3 million (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn -
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn -
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.08 Mn
Dec 31, 2024 856,870.00
Mar 31, 2024 2.28 Mn
Dec 31, 2023 2.28 Mn